|
|
||||||||
The FASEB Journal, Vol 5, 2398-2405, Copyright © 1991 by The Federation of American Societies for Experimental Biology
REVIEWS |
P Jolicoeur
Laboratory of Molecular Biology, Clinical Research Institute of Montreal, Quebec, Canada.
Murine AIDS (MAIDS) is a disease that shows many similarities with human AIDS. Several immunological parameters of the disease have been analyzed and genetic studies have mapped a gene (or genes) of resistance in the H-2 complex and shown that the genetic background of the mouse can significantly modify some features of the disease. The etiologic agent of MAIDS is a defective murine leukemia virus that seems able to induce disease in the absence of virus replication. This defective virus induces proliferation of its target cells and the cell expansion was found to be oligoclonal, thus suggesting that the immunodeficiency observed in these mice is a paraneoplastic syndrome. The excellent response of MAIDS mice to antineoplastic agents is consistent with this notion. This animal model has already been useful in stimulating the emergence of novel questions and the formulation of new hypotheses about human AIDS, namely about the role of defective HIV, the role of HIV replication in the progression of the disease, and the importance to identify the target cells of HIV in vivo. Although MAIDS and AIDS are not identical and are induced by retroviruses of different classes, the availability of such a model in an easily accessible small animal species, whose genetics is very sophisticated, may be instrumental in understanding the pathogenesis of AIDS if some of the cellular and molecular affected pathways are common in both diseases.
This article has been cited by other articles:
![]() |
Y. Kawauchi, K. Suzuki, S. Watanabe, S. Yamagiwa, H. Yoneyama, G. D. Han, S. S. Palaniyandi, P. T. Veeraveedu, K. Watanabe, H. Kawachi, et al. Role of IP-10/CXCL10 in the progression of pancreatitis-like injury in mice after murine retroviral infection. Am J Physiol Gastrointest Liver Physiol, August 1, 2006; 291(2): G345 - G354. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Chaves, R. S. Baliga, M. J. Mihm, B. L. Schanbacher, A. Basuray, C. Liu, A. C. Cook, L. W. Ayers, and J. A. Bauer Bacterial Lipopolysaccharide Enhances Cardiac Dysfunction but Not Retroviral Replication in Murine AIDS: Roles of Macrophage Infiltration and Toll-Like Receptor 4 Expression Am. J. Pathol., March 1, 2006; 168(3): 727 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Casabianca, C. Orlandi, A. Fraternale, and M. Magnani Development of a Real-Time PCR Assay Using SYBR Green I for Provirus Load Quantification in a Murine Model of AIDS J. Clin. Microbiol., September 1, 2004; 42(9): 4361 - 4364. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Beilharz, L. M. Sammels, A. Paun, K. Shaw, P. van Eeden, M. W. Watson, and M. L. Ashdown Timed Ablation of Regulatory CD4+ T Cells Can Prevent Murine AIDS Progression J. Immunol., April 15, 2004; 172(8): 4917 - 4925. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A Chaves, M. J Mihm, B. L Schanbacher, A. Basuray, C. Liu, L. W Ayers, and J. Anthony Bauer Cardiomyopathy in a murine model of AIDS: evidence of reactive nitrogen species and corroboration in human HIV/AIDS cardiac tissues Cardiovasc Res, October 15, 2003; 60(1): 108 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Dix, E. R. Podack, and S. W. Cousins Loss of the Perforin Cytotoxic Pathway Predisposes Mice to Experimental Cytomegalovirus Retinitis J. Virol., March 15, 2003; 77(6): 3402 - 3408. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Knoetig, T. A. Torrey, Z. Naghashfar, T. McCarty, and H. C. Morse III CD19 Signaling Pathways Play a Major Role for Murine AIDS Induction and Progression J. Immunol., November 15, 2002; 169(10): 5607 - 5614. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rossi, S. Serafini, P. Franchetti, A. Casabianca, C. Orlandi, G. F. Schiavano, A. Carnevali, and M. Magnani Inhibition of murine AIDS by a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine J. Antimicrob. Chemother., November 1, 2002; 50(5): 639 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rossi, S. Dominici, S. Serafini, A. Casabianca, A. Cerasi, L. Chiarantini, A. G. Celeste, L. Cappellacci, P. Franchetti, M. Grifantini, et al. Pharmacokinetic and antiretroviral activity in mice of oral [P1,P2-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine J. Antimicrob. Chemother., September 1, 2002; 50(3): 365 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Umemura, K. Hirose, W. Wajjwalku, H. Nishimura, T. Matsuguchi, Y. Gotoh, M. Takahashi, M. Makino, and Y. Yoshikai Impaired IL-15 production associated with susceptibility of murine AIDS to mycobacterial infection J. Leukoc. Biol., January 1, 2001; 69(1): 138 - 148. [Abstract] [Full Text] |
||||
![]() |
H. C. Morse III, T. McCarty, N. A. Giese, L. Taddesse-Heath, and M. J. Grusby STAT6-Deficient Mice Exhibit Normal Induction of Murine AIDS and Expression of Immunoglobulin E following Infection with LP-BM5 Murine Leukemia Viruses J. Virol., August 1, 1999; 73(8): 7093 - 7095. [Abstract] [Full Text] |
||||
![]() |
F. Vasseur, A. Le Campion, J. H. Pavlovitch, and C. Penit Distribution of Cycling T Lymphocytes in Blood and Lymphoid Organs During Immune Responses J. Immunol., May 1, 1999; 162(9): 5164 - 5172. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Casabianca, G. Vallanti, and M. Magnani Competitive PCR for Quantification of BM5d Proviral DNA in Mice with AIDS J. Clin. Microbiol., August 1, 1998; 36(8): 2371 - 2374. [Abstract] [Full Text] |
||||
![]() |
S.-M. Mayrand, D. A. Schwarz, and W. R. Green An Alternative Translational Reading Frame Encodes an Immunodominant Retroviral CTL Determinant Expressed by an Immunodeficiency-Causing Retrovirus J. Immunol., January 1, 1998; 160(1): 39 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Nguyen, J. Pavlovitch, M. Papiernik, H. Guillozo, O. Walrant-Debray, C. Pontoux, and M. Garabedian Changes in 1,25-(OH)2D3 Synthesis and Its Receptor Expression in Spleen Cell Subpopulations of Mice Infected with LPBM5 Retrovirus Endocrinology, December 1, 1997; 138(12): 5505 - 5510. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Suzuki, T Narita, R Yui, K Ohtsuka, S Inada, T Kimura, Y Okada, M Makino, T Mizuochi, H Asakura, et al. Induction of intestinal lesions in nu/nu mice induced by transfer of lymphocytes from syngeneic mice infected with murine retrovirus Gut, August 1, 1997; 41(2): 221 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
O Kanagawa, B. Vaupel, S Gayama, G Koehler, and M Kopf Resistance of mice deficient in IL-4 to retrovirus-induced immunodeficiency syndrome (MAIDS) Science, October 8, 1993; 262(5131): 240 - 242. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |